Find A Physician
Return to Research for Irritable Bowel Syndrome Overview
More on Research for Irritable Bowel Syndrome
Hospital News
Return to Research for Irritable Bowel Syndrome Overview
More on Research for Irritable Bowel Syndrome
Research and Clinical Trials
Return to Research for Irritable Bowel Syndrome Overview
More on Research for Irritable Bowel Syndrome
Health Library
Return to Research for Irritable Bowel Syndrome Overview
More on Research for Irritable Bowel Syndrome
Clinical Services
Return to Research for Irritable Bowel Syndrome Overview
More on Research for Irritable Bowel Syndrome
- Anal Fistulas
- Anorectal Cancer
- Anorectal Diseases
- Colon and Rectal Surgery
- Colorectal Cancer
- Colorectal Polyps
- Diagnosis of Colorectal Cancer
- Diagnosis of Inflammatory Bowel Disease
- Diagnosis of Irritable Bowel Syndrome
- Digestive Diseases
- Fecal Incontinence
- Hemorrhoids
- Irritable Bowel Syndrome
- Research for Colorectal Cancer
- Research for Inflammatory Bowel Disease
- Risk Factors for Colorectal Cancer
- Symptoms and Risk Factors for Irritable Bowel Syndrome
- Symptoms of Colorectal Cancer
- Symptoms of Inflammatory Bowel Disease
- Treatment for Colorectal Cancer
- Treatment for Inflammatory Bowel Disease
- Treatment for Irritable Bowel Syndrome
Digestive Diseases
Research for Irritable Bowel Syndrome
Back to the nypdigestive.org Home Page
Clinical trials and other studies conducted by NewYork-Presbyterian researchers on serotonin receptors located both in the stomach and intestines have resulted in the introduction of new drugs that can effectively treat Irritable Bowel Syndrome (IBS). Our physicians are continuing to investigate novel drugs that address the brain-gut connection, and can help make patients more comfortable.
Contact
- Digestive and Liver Diseases, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-1909
- Gastroenterology and Hepatology, NewYork-Presbyterian/Weill Cornell
-
Directions
(646) 962-4463
